APA (7th ed.) Citation

JT, F., A, S., MR, S., C, W., SP, S., T, R., . . . RH, S. (2008). Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction [corrected] [published erratum appears in CRIT CARE MED 2008 Oct;36(10): 2966]. Critical Care Medicine, 36(8), 2257. https://doi.org/10.1097/ccm.0b013e3181809846

Chicago Style (17th ed.) Citation

JT, Fuhrmann, Schmeisser A, Schulze MR, Wunderlich C, Schoen SP, Rauwolf T, Weinbrenner C, and Strasser RH. "Levosimendan Is Superior to Enoximone in Refractory Cardiogenic Shock Complicating Acute Myocardial Infarction [corrected] [published Erratum Appears in CRIT CARE MED 2008 Oct;36(10): 2966]." Critical Care Medicine 36, no. 8 (2008): 2257. https://doi.org/10.1097/ccm.0b013e3181809846.

MLA (9th ed.) Citation

JT, Fuhrmann, et al. "Levosimendan Is Superior to Enoximone in Refractory Cardiogenic Shock Complicating Acute Myocardial Infarction [corrected] [published Erratum Appears in CRIT CARE MED 2008 Oct;36(10): 2966]." Critical Care Medicine, vol. 36, no. 8, 2008, p. 2257, https://doi.org/10.1097/ccm.0b013e3181809846.